Peoples Financial Services Corp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.5M Sell
11,449
-755
-6% -$765K 4.99% 2
2025
Q4
$13.1M Sell
12,204
-274
-2% -$262K 6.12% 1
2025
Q3
$9.52M Sell
12,478
-141
-1% -$105K 4.3% 4
2025
Q2
$9.84M Sell
12,619
-589
-4% -$458K 4.86% 3
2025
Q1
$10.9M Sell
13,208
-222
-2% -$185K 5.24% 1
2024
Q4
$10.4M Sell
13,430
-288
-2% -$238K 4.8% 3
2024
Q3
$12.2M Sell
13,718
-2,107
-13% -$1.89M 5.51% 2
2024
Q2
$14.3M Sell
15,825
-460
-3% -$368K 6.48% 1
2024
Q1
$12.7M Sell
16,285
-749
-4% -$533K 5.5% 2
2023
Q4
$9.93M Sell
17,034
-111
-0.6% -$64.8K 4.3% 4
2023
Q3
$9.21M Buy
17,145
+158
+0.9% +$81.4K 4.34% 3
2023
Q2
$7.97M Sell
16,987
-303
-2% -$127K 3.57% 4
2023
Q1
$5.94M Sell
17,290
-201
-1% -$67.8K 2.77% 6
2022
Q4
$6.4M Sell
17,491
-6
-0% -$2.13K 2.99% 4
2022
Q3
$5.66M Sell
17,497
-123
-0.7% -$39K 2.92% 4
2022
Q2
$5.71M Buy
17,620
+569
+3% +$171K 2.71% 5
2022
Q1
$4.88M Sell
17,051
-530
-3% -$136K 2.11% 9
2021
Q4
$4.86M Buy
17,581
+740
+4% +$188K 1.89% 11
2021
Q3
$3.89M Buy
16,841
+65
+0.4% +$16K 1.64% 12
2021
Q2
$3.85M Sell
16,776
-45
-0.3% -$9.04K 1.61% 12
2021
Q1
$3.14M Sell
16,821
-400
-2% -$78.2K 1.37% 17
2020
Q4
$2.91M Buy
17,221
+400
+2% +$59.7K 1.34% 17
2020
Q3
$2.49M Sell
16,821
-75
-0.4% -$11.6K 1.25% 19
2020
Q2
$2.77M Buy
16,896
+1,006
+6% +$154K 1.46% 15
2020
Q1
$2.21M Sell
15,890
-335
-2% -$46K 1.3% 20
2019
Q4
$2.13M Sell
16,225
-25
-0.2% -$2.9K 1.01% 31
2019
Q3
$1.82M Sell
16,250
-25
-0.2% -$2.78K 0.91% 32
2019
Q2
$1.8M Hold
16,275
0.91% 34
2019
Q1
$2.11M Sell
16,275
-200
-1% -$24.3K 1.08% 28
2018
Q4
$1.91M Sell
16,475
-350
-2% -$39.1K 1.08% 27
2018
Q3
$1.81M Buy
16,825
+750
+5% +$75K 0.91% 34
2018
Q2
$1.37M Hold
16,075
0.77% 43
2018
Q1
$1.24M Sell
16,075
-725
-4% -$58.4K 0.71% 44
2017
Q4
$1.42M Hold
16,800
0.78% 41
2017
Q3
$1.44M Sell
16,800
-75
-0.4% -$6.15K 0.82% 36
2017
Q2
$1.39M Buy
16,875
+175
+1% +$14.3K 0.81% 36
2017
Q1
$1.4M Buy
16,700
+655
+4% +$52.5K 0.84% 34
2016
Q4
$1.26M Sell
16,045
-1,380
-8% -$103K 0.78% 39
2016
Q3
$1.4M Buy
17,425
+1,380
+9% +$110K 0.87% 34
2016
Q2
$1.26M Sell
16,045
-200
-1% -$15.1K 0.78% 39
2016
Q1
$1.17M Buy
16,245
+900
+6% +$68.1K 0.74% 41
2015
Q4
$1.29M Hold
15,345
0.85% 32
2015
Q3
$1.28M Sell
15,345
-100
-0.6% -$8.44K 0.91% 30
2015
Q2
$1.29M Sell
15,445
-200
-1% -$15.2K 0.86% 35
2015
Q1
$1.14M Buy
15,645
+2,075
+15% +$148K 0.75% 41
2014
Q4
$936K Buy
13,570
+1,100
+9% +$74.2K 0.61% 50
2014
Q3
$809K Sell
12,470
-50
-0.4% -$3.17K 0.55% 54
2014
Q2
$778K Sell
12,520
-600
-5% -$35.8K 0.49% 56
2014
Q1
$773K Sell
13,120
-100
-0.8% -$5.58K 0.57% 56
2013
Q4
$674K Buy
+13,220
New +$662K 0.44% 63

Other funds holding LLY

Peoples Financial Services Corp's LLY Position: Q1 2026 in Review

Peoples Financial Services Corp reduced its Eli Lilly (LLY) stake by 6.2% in Q1 2026, selling an estimated $765K and leaving 11,449 shares worth $10.5M. The position accounts for 4.99% of the portfolio, ranked #2.

Peoples Financial Services Corp first reported a position in LLY in Q4 2013 and has held it in 50 quarters since. The position peaked at $14.3M in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Peoples Financial Services Corp held 11,449 shares of Eli Lilly worth $10.5M as of Q1 2026.
  • Peoples Financial Services Corp sold 755 Eli Lilly shares in Q1 2026, an estimated $765K.
  • Eli Lilly made up 4.99% of Peoples Financial Services Corp's portfolio in Q1 2026, its #2 holding.
  • Peoples Financial Services Corp first reported a position in Eli Lilly in Q4 2013 and has held it in 50 quarters since.
  • Peoples Financial Services Corp's Eli Lilly position peaked at $14.3M in Q2 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Peoples Financial Services Corp's 13F filing for Q1 2026, filed 20 Apr 2026.